| ID: | 153 | |
|---|---|---|
| Name: | Compound 153 | |
| Description: | Original numeration in publication: 5c | |
| Labels: | Training_set, Phthalazines | |
| CAS: | ||
| InChi Code: | InChI=1S/C29H20ClN3O/c30-23-15-10-20(11-16-23)12-19-27(34)21-13-17-24(18-14-21)31-29-26-9-5-4-8-25(26)28(32-33-29)22-6-2-1-3-7-22/h1-19H,(H,31,33)/b19-12+ |
pIC50: Negative logarithm of half-maximal inhibitory concentration [-log(uM)]
| Value | Source or prediction |
|---|---|
| 6.2 |
Khedr, F.; Ibrahim, M.-K.; Eissa, I. H. a. A., H. S.; El-Adl, K. Phthalazine-based VEGFR-2 inhibitors: Rationale, design, synthesis, in silico, ADMET profile, docking, and anticancer evaluations. Arch. Pharm. (Weinheim) 2021, 354, e2100201. https://doi.org/10.1002/ardp.202100201 |
| 6.1172 |
Eq1: VEGFR-2 inhibition (Data used to train model) |